As of 2026-06-16, the Relative Valuation of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is (92.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.14 USD, the upside of Biohaven Pharmaceutical Holding Company Ltd based on Relative Valuation is -858.3%.
The range of the Relative Valuation is (84.75) - (89.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 24.3x | 24.2x |
| Forward P/E multiples | 18.1x - 20.7x | 18.6x |
| Fair Price | (84.75) - (89.05) | (92.06) |
| Upside | -798.1% - -833.5% | -858.3% |
| Date | P/E |
| 2026-06-15 | -2.82 |
| 2026-06-12 | -2.62 |
| 2026-06-11 | -2.64 |
| 2026-06-10 | -2.57 |
| 2026-06-09 | -2.58 |
| 2026-06-08 | -2.58 |
| 2026-06-05 | -2.51 |
| 2026-06-04 | -2.65 |
| 2026-06-03 | -2.51 |
| 2026-06-02 | -2.35 |
| 2026-06-01 | -2.66 |
| 2026-05-29 | -2.56 |
| 2026-05-28 | -2.38 |
| 2026-05-27 | -2.62 |
| 2026-05-26 | -2.34 |
| 2026-05-22 | -2.20 |
| 2026-05-21 | -2.20 |
| 2026-05-20 | -2.06 |
| 2026-05-19 | -1.95 |
| 2026-05-18 | -1.97 |
| 2026-05-15 | -2.04 |
| 2026-05-14 | -2.10 |
| 2026-05-13 | -2.10 |
| 2026-05-12 | -2.14 |
| 2026-05-11 | -2.11 |
| 2026-05-08 | -2.29 |
| 2026-05-07 | -2.26 |
| 2026-05-06 | -2.33 |
| 2026-05-05 | -2.26 |
| 2026-05-04 | -2.36 |
| 2026-05-01 | -2.24 |
| 2026-04-30 | -2.23 |
| 2026-04-29 | -2.14 |
| 2026-04-28 | -2.23 |
| 2026-04-27 | -2.23 |
| 2026-04-24 | -2.30 |
| 2026-04-23 | -2.45 |
| 2026-04-22 | -2.48 |
| 2026-04-21 | -2.37 |
| 2026-04-20 | -2.52 |
| 2026-04-17 | -2.55 |
| 2026-04-16 | -2.33 |
| 2026-04-15 | -2.41 |
| 2026-04-14 | -2.43 |
| 2026-04-13 | -2.35 |
| 2026-04-10 | -2.13 |
| 2026-04-09 | -2.18 |
| 2026-04-08 | -2.18 |
| 2026-04-07 | -2.15 |
| 2026-04-06 | -2.13 |